Pharmagreen Biotech Inc. (PHBI)
About Pharmagreen Biotech Inc.
PHARMAGREEN BIOTECH INC
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2023
- $1.6K
- Net income
- -$875.5K
- Total assets
- $209.0K
Source: SEC EDGAR · updated Jun 8, 2026
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
Pharmagreen Biotech Inc. (PHBI) Stock Price
- Reported a net loss of $875.5K in FY2023.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Pharmagreen Biotech Inc..
Write a review
Pharmagreen Biotech Inc.: frequently asked questions
Is Pharmagreen Biotech Inc. an American company?
Pharmagreen Biotech Inc. is a US-based company, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Is Pharmagreen Biotech Inc. publicly traded?
Yes — Pharmagreen Biotech Inc. is a publicly traded company. Its stock trades under the ticker symbol PHBI on the OTC.
What does Pharmagreen Biotech Inc. do?
Pharmagreen Biotech Inc. is an American Logistics & Shipping company in the Business & Financial Services sector.
